Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE)

5.45
Delayed Data
As of Jun 18
 -0.13 / -2.33%
Today’s Change
3.12
Today|||52-Week Range
9.00
+65.15%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues278.9K7.3K0.0086.0K
 
 
 
 
Depreciation And Amortization26.0K75.3K94.2K99.6K
 
 
 
 
 
 
Operating ExpensesGross Income-----94.2K--
 
 
General Expenses12.8M23.1M32.7M40.4M
 
 
 
 
 
Research And Development7.4M16.8M22.8M27.2M
 
 
 
 
 
Total Operating Expenses12.8M23.2M32.8M40.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.5M-23.2M-32.8M-40.4M
 
 
 
 
 
Other Expenses7.4K-288.6K291.2K-474.7K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.5M-23.4M-32.0M-39.9M
 
 
 
 
 
Income Taxes-27.5K-27.5K0.000.00
 
 
 
Net Income-12.6M-23.4M-32.0M-39.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.5M9.1M12.9M15.3M
 
 
 
 
 
Shares To Calculate EPS Diluted4.5M9.1M12.9M15.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.82-$2.58-$2.48-$2.61
 
 
 
 
 
EPS Diluted-$2.82-$2.58-$2.48-$2.61